Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01225822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
Not reported
Enrollment
1,973 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism